Clinical trial

Treatment for Patients Suffering From Anemia Due to Chemotherapy

NCT00120692

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Darbepoetin Alfa Normalized identity: darbepoetin alfaView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Recombinant Human Erythropoietin Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Treatment for Patients Suffering From Anemia Due to Chemotherapy

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2002-10-01

PhasePHASE2

Conditions

Breast Cancerverified · MONDO: breast cancer

Anemiaverified · MONDO: anemia

Interventions

Darbepoetin AlfaDRUG · verified · RxNorm: darbepoetin alfa

Recombinant Human ErythropoietinDRUG

Sponsors & collaborators

Amgenlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00120692 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.